Kaplan SA - Search Results

1

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DE, Padley RJ. Roehrborn CG, et al. Among authors: kaplan sa. Urology. 1996 Feb;47(2):159-68. doi: 10.1016/s0090-4295(99)80409-9. Urology. 1996. PMID: 8607227 Clinical Trial.

2

Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia).

Kaplan SA, Shabsigh R, Soldo KA, Olsson CA. Kaplan SA, et al. J Urol. 1992 Jun;147(6):1562-5. doi: 10.1016/s0022-5347(17)37626-7. J Urol. 1992. PMID: 1375661 Free article.

3

Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow.

Chancellor MB, Blaivas JG, Kaplan SA, Axelrod S. Chancellor MB, et al. Among authors: kaplan sa. J Urol. 1991 Apr;145(4):810-2. doi: 10.1016/s0022-5347(17)38458-6. J Urol. 1991. PMID: 2005706 Free article.

4

Contemporary cystectomy versus preoperative radiation plus cystectomy for bladder cancer.

Kaplan SA, Sawczuk IS, O'Toole K, Olsson CA. Kaplan SA, et al. Urology. 1988 Dec;32(6):485-91. doi: 10.1016/s0090-4295(98)90026-7. Urology. 1988. PMID: 3201654

5

Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment.

Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Seaman EK, et al. Among authors: kaplan sa. J Urol. 1994 Sep;152(3):935-7. doi: 10.1016/s0022-5347(17)32614-9. J Urol. 1994. PMID: 7519683 Free article.

6

Effect of dosing regimen on efficacy and safety of doxazosin in normotensive men with symptomatic prostatism: a pilot study.

Kaplan SA, Soldo KA, Olsson CA. Kaplan SA, et al. Urology. 1994 Sep;44(3):348-52. doi: 10.1016/s0090-4295(94)80092-8. Urology. 1994. PMID: 7521090 Clinical Trial.

7

The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.

Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. Oesterling JE, et al. Among authors: kaplan sa. Urology. 1994 Sep;44(3):353-62. doi: 10.1016/s0090-4295(94)80093-6. Urology. 1994. PMID: 7521091 Clinical Trial.

8

Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia.

Kaplan SA, Goluboff ET, Olsson CA, Deverka PA, Chmiel JJ. Kaplan SA, et al. Urology. 1995 Mar;45(3):398-405. doi: 10.1016/S0090-4295(99)80007-7. Urology. 1995. PMID: 7533451 Clinical Trial.

9

Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.

Kaplan SA, Te AE. Kaplan SA, et al. Urology. 1995 Apr;45(4):566-72. doi: 10.1016/S0090-4295(99)80044-2. Urology. 1995. PMID: 7536365 Clinical Trial.

10

Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.

Kaplan SA, Te AE, Pressler LB, Olsson CA. Kaplan SA, et al. J Urol. 1995 Nov;154(5):1764-9. J Urol. 1995. PMID: 7563342 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,018 results

Search Page

Filters